Mark Smith
Director/Board Member at Freya Biosciences ApS
Net worth: 142 092 $ as of 2024-04-29
Mark Smith active positions
| Companies | Position | Start | End |
|---|---|---|---|
Freya Biosciences ApS
 Freya Biosciences ApS Miscellaneous Commercial ServicesCommercial Services Freya Biosciences ApS is a clinical-stage biotech company based in Copenhagen, Denmark, that is dedicated to advancing women's reproductive health. The Danish company focuses on reproductive microbial immunotherapy interventions to improve fertility outcomes and empower women with innovative solutions. Freya Biosciences aims to address immune drivers underlying a range of reproductive health conditions to create a future where everyone is empowered with optimal reproductive health. The company was founded by Johan van Hylckama Vlieg, Colleen Acosta, Randi Rich, and Ulrich Binné, and Colleen Acosta has been the CEO since incorporation. | Director/Board Member | - | - |
Career history of Mark Smith
Former positions of Mark Smith
| Companies | Position | Start | End |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Director/Board Member | 2017-08-31 | 2023-05-14 |
| Chief Executive Officer | 2017-08-31 | 2023-05-14 | |
| Founder | 2017-08-31 | 2023-05-14 | |
The Microbiome Health Research Institute, Inc.
 The Microbiome Health Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Microbiome Health Research Institute, Inc. operates a public stool bank. It specializes in stool preparations to clinicians for fecal microbiota transplantation and to catalyse research into the human microbiome. The company was founded by James Burgess and Mark Smith in 2012 and is headquartered in Somerville, MA. | Director/Board Member | 2011-12-31 | 2016-06-30 |
| Chief Tech/Sci/R&D Officer | 2011-12-31 | 2016-06-30 | |
| Founder | 2011-12-31 | 2016-06-30 | |
| President | 2011-12-31 | 2016-06-30 |
Training of Mark Smith
| Massachusetts Institute of Technology | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Denmark | 2 |
Operational
| Director/Board Member | 3 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Commercial Services | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Private companies | 2 |
|---|---|
The Microbiome Health Research Institute, Inc.
The Microbiome Health Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Microbiome Health Research Institute, Inc. operates a public stool bank. It specializes in stool preparations to clinicians for fecal microbiota transplantation and to catalyse research into the human microbiome. The company was founded by James Burgess and Mark Smith in 2012 and is headquartered in Somerville, MA. | Commercial Services |
Freya Biosciences ApS
Freya Biosciences ApS Miscellaneous Commercial ServicesCommercial Services Freya Biosciences ApS is a clinical-stage biotech company based in Copenhagen, Denmark, that is dedicated to advancing women's reproductive health. The Danish company focuses on reproductive microbial immunotherapy interventions to improve fertility outcomes and empower women with innovative solutions. Freya Biosciences aims to address immune drivers underlying a range of reproductive health conditions to create a future where everyone is empowered with optimal reproductive health. The company was founded by Johan van Hylckama Vlieg, Colleen Acosta, Randi Rich, and Ulrich Binné, and Colleen Acosta has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Mark Smith
- Experience